![](/img/cover-not-exists.png)
1958. Antiviral Effects, Pharmacokinetics (PK), and Safety of the Respiratory Syncytial Virus (RSV) Fusion Protein Inhibitor, JNJ-53718678 (JNJ-8678), in RSV-infected Infants With Bronchiolitis, in the Phase 1b Study 53718678RSV1005
Martinon-Torres, Federico, Rusch, Sarah, Huntjens, Dymphy, Remmerie, Bart, Vingerhoets, Johan, McFadyen, Katie, Ferrero, Fernando, Baraldi, Eugenio, Conejo, Pablo Rojo, Epalza, Cristina, Stevens, MariVolume:
5
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofy210.1614
Date:
November, 2018
File:
PDF, 1.38 MB
2018